Skip to main content
Premium Trial:

Request an Annual Quote

BHB Licenses Life Technologies' PCR Patents

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bar Harbor Biotechnology said today that it has licensed PCR and real-time PCR patents from Life Technologies.

The agreement enables BHB to provide contract research services based on its StellARray and XenoQ systems. Researchers can purchase assays based on those two technologies through BHB's exclusive distributor, Lonza. BHB would then perform the PCR services and analyze the data using the Global Patter Recognition analysis software, which is exclusive to the firm.

"We believe there are many laboratories that do not have the resources to utilize our technology," BHB's VP of Product Development, Dan Shaffer, said in a statement. "We wanted to change that and make it easier for all labs to make use of our systems."

BHB said that it has expanded its staff to incorporate the new services, and CEO Robert Phelps said that the expansion was made possible with support from the State of Maine. "This new expansion was part of a strategic plan to create new high tech jobs here in Maine," he said.

Financial terms of the agreement were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.